Shares in Shire raced to the top of the FTSE 100 on Thursday after the pharmaceutical giant looked set to become the centre of a takeover tussle between Botox maker Allergan and Japan’s Takeda. Shares in Shire raced to the top of the FTSE 100 on Thursday after the pharmaceutical giant looked set to become the centre of a takeover tussle between Botox maker Allergan and Japan’s Takeda. FTSE ends up as Shire shares soar on takeover approachesThe Irish drug-maker said on Thursday that it had rebuffed three offers from Takeda, the latest worth £44 billion, because they “significantly undervalued the company, its growth prospects and pipeline”. The disclosures sent shares in London-listed Shire soaring, with the stock ending the day up 221p to 3,975p. The biggest risers on the FTSE 100 were Shire up 221p to 3,975p, Rentokil up 12.3p to 285.2p, WPP up 40p to 1,156p and NMC Health up 96p to 3,596p.

Source: Irish Independent April 19, 2018 16:18 UTC